Navigation Links
EMD Serono launches easypod, new electronic growth hormone injection device
Date:12/6/2007

Rockland, Massachusetts, December 6, 2007 - EMD Serono, Inc. announced today the availability of easypod, the first of its kind automated device in the growth hormone therapeutic area. easypod was developed for the administration of Saizen [somatropin (rDNA origin) for injection], the companys treatment for growth hormone deficiency. A 2007 Gold Medal recipient of the Medical Design Excellence Awards, easypod was designed in conjunction with patients, caregivers and healthcare professionals to answer the need for a device that provided simple everyday use while monitoring patient adherence. On October 31, 2007, easypod received approval from the US Food and Drug Administration (FDA) and is now available to patients through their healthcare providers.

As a physician who treats children with growth hormone deficiency, I am encouraged by the new technology in easypod, said Henry Anhalt, D.O., FAAP, FACOP, FACE, CDE, Director of the Division of Pediatric Endocrinology and Diabetes at Saint Barnabas Medical Center. It is the first growth hormone delivery device that allows healthcare professionals to preset their patients daily dose in advance and then monitor their compliance to the treatment schedule.

Over seven hundred patients, caregivers and healthcare professionals were surveyed for input on how to improve upon delivery systems for growth hormone therapy during the development phase of easypod. One of the key features of easypod is preset dosing, which means patients no longer have to set their dose each day. Another unique feature is the dose confirmation screen that notifies patients when they have properly administered their treatment. easypod also logs the date and dose of each injection, allowing healthcare professionals to monitor patient adherence.

We are proud to bring products like easypod to market that utilize breakthrough technology to provide patients and healthcare professionals with devices that are simple to use
'/>"/>

Contact: Michele Baer
michele@baerconsulting.com
973-233-0044
Baer Consulting
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related biology news :

1. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
2. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
3. $22 million gift from Alfred Taubman launches new biomedical research institute
4. BioMed Central launches Biology Image Library
5. Arizona State University launches biofuel initiative with BP and Science Foundation Arizona
6. UW launches cutting-edge DNA fin-printing project for salmon
7. SLIM Search Launches Academic Pricing Program
8. Salmon garnish points the way to green electronics
9. IGERT fellows to design biodevices using flexible electronics
10. Model for the assembly of advanced, single-molecule-based electronic components developed at Pitt
11. MITs electronic nose could detect hazards

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...research suggests that a common oral bacterium may...t by Nichols et al, "Unique Lipids from a Common H...ds Capable of Enhancing Autoimmunity," appears in ...f Pathology . , Multiple sclerosis (MS), a disea...pinal cord, affects nearly 1 in 700 people in the ...
(Date:11/23/2009)...swine vaccine available for the H1N1 virus has bee... virus. The vaccination marks the first time vacci...e pandemic flu., Iowa State University,s Hank Ha...accine this summer and has been shipping preventiv...inois for several weeks., The latest vaccines we...
(Date:11/23/2009)..., 2009 -- A USDOE and USDA study concluded that 50...d cropland pasture could be converted from current... as switchgrass, from which biomass could be harve...viable production of a perennial grass monoculture...removed annually is expected to require nitrogen f...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2How Well Do You Sleep At Night 3F Visit The New Online Aviisha Medical Wellness Institute To Find Out 54874 1How Well Do You Sleep At Night 3F Visit The New Online Aviisha Medical Wellness Institute To Find Out 54874 2How Well Do You Sleep At Night 3F Visit The New Online Aviisha Medical Wellness Institute To Find Out 54874 3Misuse of Pain Medication Draws Heightened Concerns 54870 1Misuse of Pain Medication Draws Heightened Concerns 54870 2Misuse of Pain Medication Draws Heightened Concerns 54870 3Misuse of Pain Medication Draws Heightened Concerns 54870 4Anthem Blue Cross and Blue Shield in Maine Announces Decision to Cover H1N1 Vaccine Administration 54866 1Anthem Blue Cross and Blue Shield in Maine Announces Decision to Cover H1N1 Vaccine Administration 54866 2
...ch sun ?for plants as well as people ?can be harmf... equivalent of "lobster tans," plants have develop... photoprotection, which acts like sunscreen to war...olecules called carotenoids participate in this pr...n, how does this work?" said Iris Visoly-Fisher, a...
...e first time, researchers have developed a way to ...in in enough quantity to learn how it works. , Der...s of a New Zealand cave, the chemical tricks certa... cells untouched. , "In 2000, scientists in Japan...mendous potential as a prototype anticancer agent,...
...g a whole new interface between nanotechnology and...ve used slender silicon nanowires to detect, stimu...d dendrites of live mammalian neurons. , Harvard ... this marriage of nanowires and neurons this week ... artificial synapses between nanoelectronic device...
Other Biology News:How plants avoid feeling the burn 2How plants avoid feeling the burn 3How plants avoid feeling the burn 4New lab technique churns out fungus' potential cancer fighter 2Nanowire arrays can detect signals along individual neurons 2
(Date:11/24/2009)...land,November24/PRNewswire-FirstCall/--deCODE,gene...fallofits,"firstday"motionsbytheU.S.BankruptcyCour...eCODElastweekfiledavoluntarypetitionfor,reliefunde...ankruptcyCourt. , TheordersissuedbytheBankrup...nessduringtheChapter11proceedings.Inparticular,the...
(Date:11/24/2009)...24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,C...rovedthe,investigationalnewdrugapplication(IND)for...formulationtotreatdiabetes.ThisIND,approvalallowsB..., Diabetesisadisordercharacteristicofhighbloodgluc...tenresultinseveremicro-and,macro-vasculardiseases,...
(Date:11/24/2009)...cyendpointhasbeenmetforpatientswithadvanced-stage,...v.24/PRNewswire-FirstCall/-AEternaZentarisInc.(NAS...ceuticalcompanyfocusedonendocrinetherapyandoncolog...dywithitstargetedcytotoxicpeptideconjugate,AEZS-10...tendometrialcancer.Inapersonalizedhealthcareapproa...
(Date:11/24/2009)...24,2009/PRNewswire-FirstCall/--ArenaPharmaceutical...yisscheduledtopresentatthePiperJaffray21stAnnualHe...rnTime(8:30a.m.PacificTime)attheNewYorkPalaceHotel...xecutiveOfficer,isscheduledtoprovideanoverviewofth...ryprograms. ,, Aliveaudiowebcastofthepresentati...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
... Separate Study Also Show Minimal Effect on Heart ...Patients, VIENNA, Austria, Oct. 17 New data show...ng developed by Organon -- is effective,in treatin...isorder. These,results, from two Phase III clinica...ropean College of Neuropsychopharmacology (ECNP) C...
...st time theoretical modeling has provided a glimps... to trap charges, something which may affect the p... revealed in a paper published on the 12th October...London Centre for Nanotechnology and SEMATECH, a c...uest for miniaturization, transistors and all thei...
..., Oct. 16 NxStage Medical,Inc. (Nasdaq: NXTM ), ...ucts, announced plans to release its financial res...r 2, 2007 before the opening of the,financial mark...10:00 a.m. Eastern Time on,November 2, 2007 to dis...listen to the conference call, please dial 800.638...
Other Biology Technology:Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 2Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 3Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 4Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 5Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 6Novel gate dielectric materials: perfection is not enough 2NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd 2
Bsg I from New England Biolabs
Rabbit Anti-CUGBP2 Monoclonal Antibody, Unconjugated, Clone PADZMD.495 from Invitrogen
GIBCO Geneticin Selective Antibiotic liquid from Invitrogen
LB Broth Base powder (Lennox L Broth Base) from Invitrogen
Biology Products: